Microbiota intestinal, probióticos y su relación con el trastorno depresivo mayor: una revisión bibliográfica
DOI:
https://doi.org/10.36097/rsan.v1i58.2756Keywords:
microbiota, depresión, probióticos, neuroinflamación, eje intestino – cerebroAbstract
El trastorno depresivo mayor (TDM) ha ganado relevancia en los últimos años, ya que es una de las principales causas de discapacidad a nivel mundial y ejerce un impacto significativo en la vida diaria de quienes lo experimentan. La relación entre la disbiosis intestinal y el TDM ha surgido como un componente crucial en el ámbito de la salud mental. La microbiota intestinal, que abarca una amplia diversidad de microorganismos, establece una conexión bidireccional con el TDM a través del eje microbiota-intestino-cerebro, la neuroinflamación y alteración de la función cerebral. El presente trabajo tuvo como objetivo, analizar la relación entre los problemas de equilibrio de los microorganismos en el intestino (fenómeno conocido como “disbiosis”) y el TDM. Se adoptó un enfoque cualitativo que combinó análisis bibliográfico y descriptivo, priorizando fuentes primarias en psicología, neurociencia y microbiología. Se examinaron investigaciones en inglés y español desde 2019 hasta 2023 utilizando motores de búsqueda y bases de datos reconocidas. En este contexto, se observó que el uso de probióticos se ha vuelto cada vez más relevante como parte del tratamiento complementario para el TDM. Los probióticos, como Lactobacillus plantarum DP189 y la bacteria Roseburia intestinalis, ejercen un impacto positivo en la microbiota intestinal, integridad de la barrera hematoencefálica y producción de neurotransmisores. La revisión destaca el papel crucial de la microbiota intestinal en el TDM y la prometedora utilidad de los probióticos como tratamiento complementario. Esto sugiere nuevas perspectivas terapéuticas y subraya
References
Aguilera, M., Cerdà-Cuéllar, M., & Martínez, V. (2015). Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice. Gut microbes, 6(1), 10-23. https://doi.org/10.4161/19490976.2014.990790
American Psychiatric Association. (2023). DSM-5-TR® Manual Diagnóstico y Estadístico de los Trastornos Mentales. Editorial Médica Panamericana. https://www.federaciocatalanatdah.org/wp-content/uploads/2018/12/dsm5-manualdiagnsticoyestadisticodelostrastornosmentales-161006005112.pdf
Baek, S-H., Kim, H., Kim, J-W., Ryu, S., Lee, J-Y., Kim, J-M., et al. (2022). Association between peripheral inflammatory cytokines and cognitive function in patients with first-episode schizophrenia. Journal of Personalized Medicine, 12(7), 1137. https://doi.org/10.3390/jpm12071137
Bastiaanssen, T. F. S., Cowan, C. S. M., Claesson, M. J., Dinan, T. G., & Cryan, J. F. (2020). Making Sense of... the Microbiome in Psychiatry. The International Journal of Neuropsychopharmacology, 23(1), 37-52. https://doi.org/10.1093/ijnp/pyy067
Cangalaya, C., Wegmann, S., Sun, W., Diez, L., Gottfried, A., Richter, K., et al. (2023). Real-time mechanisms of exacerbated synaptic remodeling by microglia in acute models of systemic inflammation and tauopathy. Brain, Behavior, and Immunity, 110, 245-259. https://doi.org/10.1016/j.bbi.2023.02.023
Cenit, M. C., Sanz, Y., & Codoñer-Franch, P. (2017). Influence of gut microbiota on neuropsychiatric disorders. World Journal of Gastroenterology, 23(30), 5486. https://doi.org/10.3748%2Fwjg.v23.i30.5486
Cheung, S. G., Goldenthal, A. R., Uhlemann, A. C., Mann, J. J., Miller, J. M., & Sublette, M. E. (2019). Systematic review of gut microbiota and major depression. Frontiers in psychiatry, 10, 34. https://doi.org/10.3389/fpsyt.2019.00034
El Dib, R., Periyasamy, A. G., de Barros, J. L., França, C. G., Senefonte, F. L., Vesentini, G., et al. (2021). Probiotics for the treatment of depression and anxiety: A systematic review and meta-analysis of randomized controlled trials. Clinical Nutrition ESPEN, 45, 75-90. https://doi.org/10.1016/j.clnesp.2021.07.027
Evrensel, A., & Ceylan, M. E. (2015). The gut-brain axis: the missing link in depression. Clinical psychopharmacology and neuroscience, 13(3), 239. https://doi.org/10.9758%2Fcpn.2015.13.3.239
Harsanyi, S., Kupcova, I., Danisovic, L., & Klein, M. (2022). Selected biomarkers of depression: What are the effects of cytokines and inflammation? International Journal of Molecular Sciences, 24(1), 578. https://doi.org/10.3390%2Fijms24010578
Hu, H., Yang, X., He, Y., Duan, C., & Sun, N. (2022). Psychological stress induces depressive-like behavior associated with bone marrow-derived monocyte infiltration into the hippocampus independent of blood-brain barrier disruption. Journal of Neuroinflammation, 19(1), 208. https://doi.org/10.1186/s12974-022-02569-w
Hu, Y., Yiu, V., & Clark, R. (2021). Etiology of depression: Biological and environmental factors in the development of depression. Journal of Studies in Research, 10(4). https://doi.org/10.47611/jsrhs.v10i4.2017
Huang, T. T., Lai, J. B., Du, Y. L., Xu, Y., Ruan, L. M., & Hu, S. H. (2018). Current understanding of gut microbiota in mood disorders: An update of human studies. Frontiers in genetics, 9, 98. https://doi.org/10.3389%2Ffgene.2019.00098
Jiang, H., Ling, Z., Zhang, Y., Mao, H., Ma, Z., Yin, Y., et al. (2015). Altered fecal microbiota composition in patients with major depressive disorder. Brain, behavior, and immunity, 48, 186-194. https://doi.org/10.1016/j.bbi.2015.03.016
Johnson, D., Letchumanan, V., Thum, C. C., Thurairajasingam, S., & Lee, L.-H. (2023). A microbial-based approach to mental health: The potential of probiotics in the treatment of depression. Nutrients, 15(6). https://doi.org/10.3390/nu15061382
Kelly, J. R., Borre, Y., O'Brien, C., Patterson, E., El Aidy, S., Deane, J., et al. (2016). Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat. Journal of Psychiatric Research, 82, 109-118. https://doi.org/10.1016/j.jpsychires.2016.07.019
Latif, A., Shehzad, A., Niazi, S., Zahid, A., Ashraf, W., Iqbal, M. W., et al. (2023). Probiotics: mechanism of action, health benefits and their application in food industries. Frontiers in Microbiology, 14, 1216674. https://doi.org/10.3389/fmicb.2023.1216674
Liu, R. T., Walsh, R. F. L., & Sheehan, A. E. (2019). Prebiotics and probiotics for depression and anxiety: A systematic review and meta-analysis of controlled clinical trials. Neuroscience & Biobehavioral Reviews, 102, 13-23. https://doi.org/10.1016/j.neubiorev.2019.03.023
McIntyre, R. S. (2020). Major Depressive Disorder. En C. Rong, M. Subramaniapillai y Y. Lee (Eds.). Health Sciences Division. Filadelfia. https://www.mea.elsevierhealth.com/major-depressive-disorder-9780323581318.html
McKenzie, R., Maarsingh, J., Laniewski, P., & Herbst-Kralovetz, M. (2022). Immunometabolic analysis of Mobiluncus mulieris and Eggerthella sp. Reveals novel insights into their pathogenic contributions to the hallmarks of bacterial vaginosis. American Journal of Obstetrics and Gynecology, 226(2), 316. https://doi.org/10.3389/fcimb.2021.759697
Mitrea, L., Nemeş, S. A., Szabo, K., Teleky, B. E., & Vodnar, D. C. (2022). Guts Imbalance Imbalances the Brain: A Review of Gut Microbiota Association With Neurological and Psychiatric Disorders. Frontiers in Medicine (Lausanne), 9, 813204. https://doi.org/10.3389%2Ffmed.2022.813204
Mohr, A. E., Crawford, M., Jasbi, P., Fessler, S., & Sweazea, K. L. (2022). Lipopolysaccharide and the gut microbiota: Considering structural variation. FEBS Letters, 596(7), 849-875. https://doi.org/10.1002/1873-3468.14328
Moreno-Agostino, D., Wu, Y.-T., Daskalopoulou, C., Hasan, M. T., Huisman, M., & Prina, M. (2021). Global trends in the prevalence and incidence of depression: A systematic review and meta-analysis. Journal of Affective Disorders, 281, 235-243. https://doi.org/10.1016/j.jad.2020.12.035
Naseribafrouei, A., Hestad, K., Avershina, E., Sekelja, M., Linløkken, A., Wilson, R., & Rudi, K. (2014). Correlation between the human fecal microbiota and depression. Neurogastroenterology & Motility, 26(8), 1155-1162. https://doi.org/10.1111/nmo.12378
Nikolova, V. L., Cleare, A. J., Young, A. H., & Stone, J. M. (2021). Updated review and meta-analysis of probiotics for the treatment of clinical depression: Adjunctive vs. Stand-alone treatment. Journal of Clinical Medicine, 10(4), 647. https://doi.org/10.3390/jcm10040647
Nikolova, V., Zaidi, S. Y., Young, A. H., Cleare, A. J., & Stone, J. M. (2019). Gut feeling: Randomized controlled trials of probiotics for the treatment of clinical depression: Systematic review and meta-analysis. Therapeutic Advances in Psychopharmacology, 9, 2045125319859963. https://doi.org/10.1177/2045125319859963
Olsson, L. M., Boulund, F., Nilsson, S., Khan, M. T., Gummesson, A., Fagerberg, L., et al. (2022). Dynamics of the normal gut microbiota: A longitudinal one-year population study in Sweden. Cell Host Microbe, 30(5), 726-739.e3. https://doi.org/10.1016/j.chom.2022.03.002
Rauf, A., Badoni, H., Abu-Izneid, T., Olatunde, A., Rahman, M. M., Painuli, S., et al. (2022). Neuroinflammatory markers: Key indicators in the pathology of neurodegenerative diseases. Molecules, 27(10), 3194. https://doi.org/10.3390%2Fmolecules27103194
Schildkraut, J. J. (2020). The catecholamine hypothesis. En The Psychopharmacologists III (p. 111-134). CRC Press. https://doi.org/10.1176/ajp.122.5.509
Sherwin, E., Sandhu, K. V., Dinan, T. G., & Cryan, J. F. (2016). May the force be with you: the light and dark sides of the microbiota–gut–brain axis in neuropsychiatry. CNS drugs, 30(11), 1019-1041. https://doi.org/10.1007/s40263-016-0370-3
Slyepchenko, A., Maes, M., Machado-Vieira, R., Anderson, G., Solmi, M., Sanz, Y., et al. (2021). Intestinal dysbiosis, gut hyperpermeability and bacterial translocation: missing links between depression and cardiovascular disease? Current pharmaceutical design, 27(18), 1829-1840. https://doi.org/10.2174/1381612822666160922165706
Sun, Z., Wang, X., Feng, S., Xie, C., Xing, Y., Guo, L., et al. (2023). A review of neuroendocrine immune system abnormalities in IBS based on the brain-gut axis and research progress of acupuncture intervention. Frontiers in Neuroscience, 17, 934341. https://doi.org/10.3389/fnins.2023.934341
Tiwari, P., Dwivedi, R., Bansal, M., Tripathi, M., & Dada, R. (2023). Role of Gut Microbiota in Neurological Disorders and Its Therapeutic Significance. Journal of Clinical Medicine, 12(4), 1650. https://doi.org/10.3390/jcm12041650
Vu, A. P., Lam, D., Denney, C., Lee, K. V., Plemel, J. R., & Jackson, J. (2023). Social isolation produces a sex- and brain region-specific alteration of microglia state. European Journal of Neuroscience, 57(9), 1481-1497. https://doi.org/10.1111/ejn.15966
Wang, H., Lee, I. S., Braun, C., & Enck, P. (2016). Effect of probiotics on central nervous system functions in animals and humans: a systematic review. Journal of Neurogastroenterology and Motility, 22(4), 589. https://doi.org/10.5056/jnm16018
Wang, X., Zhou, H., & Zhu, X. (2020). Attention deficits in adults with Major depressive disorder: A systematic review and meta-analysis. Asian Journal of Psychiatry, 53, 102359. https://doi.org/10.1016/j.ajp.2020.102359
Wang, Y., Zhu, J., Zou, N., Zhang, L., Wang, Y., Zhang, M., et al. (2023). Pathogenesis from the microbial-gut-brain axis in white matter injury in preterm infants: A review. Frontiers in Integrative Neuroscience, 17, 1051689. https://doi.org/10.3389/fnint.2023.1051689
Yang, Q., Stewart, S. N., & Zhang, G. (2022). Gut microbiome and poultry health. En Gut Microbiota, Immunity, and Health in Production Animals (pp. 69-84). Springer International Publishing. http://dx.doi.org/10.1007/978-3-030-90303-9_5
Zhang, C., Ma, K., Nie, K., Deng, M., Luo, W., Wu, X., et al. (2022). Assessment of the safety and probiotic properties of Roseburia intestinalis: A potential "Next Generation Probiotic". Frontiers in Microbiology, 13, 973046. https://doi.org/10.3389%2Ffmicb.2022.973046
Zhang, Q., Chen, B., Zhang, J., Dong, J., Ma, J., Zhang, Y., et al. (2023). Effect of prebiotics, probiotics, symbiotics on depression: Results from a meta-analysis. BMC Psychiatry, 23(1), 477. https://doi.org/10.1186/s12888-023-04963-x
Zhao, Y., Yang, G., Zhao, Z., Wang, C., Duan, C., Gao, L., et al. (2020). Antidepressant-like effects of Lactobacillus plantarum DP189 in a corticosterone-induced rat model of chronic stress. Behavioral Brain Research, 395, 112853. https://doi.org/10.1016/j.bbr.2020.112853
Zheng, P., Zeng, B., Zhou, C., Liu, M., Fang, Z., Xu, X., et al. (2016). Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism. Molecular Psychiatry, 21(6), 786-796. https://doi.org/10.1038/mp.2016.44
Zheng, Y., Zhang, Z., Tang, P., Wu, Y., Zhang, A., Li, D., et al. (2023). Probiotics fortify intestinal barrier function: A systematic review and meta-analysis of randomized trials. Frontiers in Immunology, 14, 1143548. https://doi.org/10.3389/fimmu.2023.1143548
Zhou, M., Fan, Y., Xu, L., Yu, Z., Wang, S., Xu, H., et al. (2023). Microbiome and tryptophan metabolomics analysis in adolescent depression: Roles of the gut microbiota in the regulation of tryptophan-derived neurotransmitters and behaviors in human and mice. Microbiome, 11(1), 145. https://doi.org/10.1186/s40168-023-01589-9
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Angel Alberto Barcia Jijón, Mario A. García Pérez, René Tejedor Arias
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Esta obra está bajo una Licencia Creative Commons Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0).
